T0	Participants 44 66	patients undergoing H.
T1	Participants 67 86	pylori eradication.
T2	Participants 402 439	One hundred and ninety-three (193) H.
T3	Participants 440 464	pylori-positive patients
T4	Participants 530 547	Group A (N = 64):
T5	Participants 593 610	Group B (N = 64):
T6	Participants 670 687	Group C (N = 65):
T7	Participants 925 937	All patients
T8	Participants 1050 1096	One hundred and eighty-eight out of the 193 H.
T9	Participants 1097 1146	pylori-positive patients (96%) completed therapy.
T10	Participants 1477 1498	193 enrolled subjects